{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:53:13Z","timestamp":1784163193656,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":337,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.ctarc.2020.100264","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T12:49:16Z","timestamp":1607086156000},"page":"100264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"Michiel","family":"Vlaming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambertus A.L.M.","family":"Kiemeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctarc.2020.100264_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100264_bib0002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1200\/JCO.2014.57.6967","article-title":"Improving selection criteria for early cystectomy in high-grade T1 bladder cancer: a meta-analysis of 15,215 patients","volume":"33","author":"Martin-Doyle","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100264_bib0003","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eururo.2013.11.046","article-title":"EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2013 Guidelines","volume":"65","author":"Witjes","year":"2014","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100264_bib0004","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.eururo.2012.02.028","article-title":"Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: long-Term Results in 1100 Patients","volume":"61","author":"Hautmann","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100264_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41598-018-26002-6","article-title":"Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: a Systematic Review and Meta-analysis","volume":"8","author":"Ge","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100264_bib0006","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eururo.2003.10.006","article-title":"Prognosis of Muscle-Invasive Bladder Cancer: difference between Primary and Progressive Tumours and Implications for Therapy","volume":"45","author":"Schrier","year":"2004","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100264_bib0007","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/bju.12403","article-title":"Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis","volume":"113","author":"Breau","year":"2014","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100264_bib0008","doi-asserted-by":"crossref","first-page":"e969","DOI":"10.1016\/j.clgc.2018.04.004","article-title":"History of non\u2013muscle-invasive bladder cancer may have a worse prognostic impact in cT2-4aN0M0 bladder cancer patients treated with radical cystectomy","volume":"16","author":"Kayama","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2020.100264_bib0009","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4111\/kju.2007.48.11.1109","article-title":"The difference in the prognosis and characteristics between the progressive and primary muscle-invasive bladder cancer treated with radical cystectomy","volume":"48","author":"Lee","year":"2007","journal-title":"Korean J Urol"},{"issue":"4S","key":"10.1016\/j.ctarc.2020.100264_bib0010","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/j.juro.2013.02.3171","article-title":"1621 Oncological Outcome of Radical Cystectomy for Bcg Failure Compared To Primary Invasive Disease","volume":"189","author":"Masson-Lecomte","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100264_bib0011","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bju.13146","article-title":"Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy","volume":"117","author":"Moschini","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.ctarc.2020.100264_bib0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2490-13-23","article-title":"The natural history of secondary muscle-invasive bladder cancer","volume":"13","author":"Hidas","year":"2013","journal-title":"BMC Urol"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100264_bib0013","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00345-012-0832-2","article-title":"Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes","volume":"30","author":"Kotb","year":"2012","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100264_bib0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000350232","article-title":"Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy","volume":"91","author":"Aziz","year":"2013","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100264_bib0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejso.2009.11.012","article-title":"Survival after cystectomy for invasive bladder cancer","volume":"36","author":"de Vries","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100264_bib0016","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000107950","article-title":"Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate","volume":"79","author":"Ferreira","year":"2007","journal-title":"Urol Int"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100264_bib0017","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.urology.2007.02.064","article-title":"Early-Stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion","volume":"69","author":"Lee","year":"2007","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.ctarc.2020.100264_bib0018","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00120-007-1361-2","article-title":"Stellen wir die indikation zur radikalen zystektomie immer zeitgerecht","volume":"46","author":"May","year":"2007","journal-title":"Urol - Ausgabe A"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100264_bib0019","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.clgc.2013.11.014","article-title":"EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer","volume":"12","author":"May","year":"2014","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100264_bib0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.urology.2007.05.008","article-title":"Muscle-Invasive Bladder Cancer: predictive Factors and Prognostic Difference Between Primary and Progressive Tumors","volume":"70","author":"T\u00fcrk\u00f6lmez","year":"2007","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100264_bib0021","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1046\/j.1464-4096.2001.001020.x","article-title":"Outcome of radical cystectomy for bladder cancer according to the disease type at presentation","volume":"89","author":"Yiou","year":"2002","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100264_bib0022","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422030099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422030099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:24:11Z","timestamp":1762842251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422030099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":22,"alternative-id":["S246829422030099X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2020.100264","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2020.100264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100264"}}